SecSonar.com

Boston Scientific Corporation (BSX)

Boston Scientific Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Boston Scientific Corporation (BSX) is a Medical - Devices company based in US with a market capitalization of $71.7B. Revenue grew 19.9% year-over-year and the company generated $3.7B in free cash flow. This page tracks BSX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 53K employees · IPO May 19, 1992

Valuation

Valuation & price

$52.68 · as of May 17, 2026 · -51.3% vs 52w high

27.3

P/E ratio

Latest-FY diluted EPS

2.96

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$108$76.16$44.23Jul 25Dec 25Jul 26Jul 7, 25$103.83Jul 9, 25$102.96Jul 11, 25$103.20Jul 15, 25$103.48Jul 17, 25$104.65Jul 21, 25$103.78Jul 23, 25$107.76Jul 25, 25$106.14Jul 29, 25$106.47Jul 31, 25$104.92Aug 4, 25$106.79Aug 6, 25$102.95Aug 11, 25$102.75Aug 13, 25$102.50Aug 15, 25$103.17Aug 19, 25$103.75Aug 21, 25$105.21Aug 25, 25$105.11Aug 27, 25$105.87Aug 29, 25$105.50Sep 3, 25$107.53Sep 5, 25$107.22Sep 9, 25$108.09Sep 11, 25$104.34Sep 16, 25$98.98Sep 18, 25$98.23Sep 22, 25$97.03Sep 24, 25$98.06Sep 26, 25$98.18Sep 30, 25$97.63Oct 2, 25$96.22Oct 6, 25$96.70Oct 8, 25$96.79Oct 10, 25$95.41Oct 14, 25$96.24Oct 16, 25$97.78Oct 21, 25$99.90Oct 23, 25$102.39Oct 27, 25$102.43Oct 29, 25$100.30Oct 31, 25$100.72Nov 4, 25$98.84Nov 6, 25$99.05Nov 10, 25$100.91Nov 12, 25$104.13Nov 14, 25$102.69Nov 18, 25$99.22Nov 20, 25$96.60Nov 25, 25$101.36Nov 28, 25$101.58Dec 2, 25$99.02Dec 4, 25$97.72Dec 8, 25$93.84Dec 10, 25$92.70Dec 12, 25$92.58Dec 16, 25$92.95Dec 18, 25$96.11Dec 22, 25$96.43Dec 24, 25$96.13Dec 29, 25$95.76Jan 2, 26$94.71Jan 6, 26$97.79Jan 8, 26$98.38Jan 12, 26$95.72Jan 14, 26$93.74Jan 16, 26$88.07Jan 21, 26$91.71Jan 23, 26$92.51Jan 27, 26$93.61Jan 29, 26$92.33Feb 2, 26$91.87Feb 4, 26$75.50Feb 9, 26$74.12Feb 11, 26$73.47Feb 13, 26$74.73Feb 18, 26$76.28Feb 20, 26$74.58Feb 24, 26$75.15Feb 26, 26$75.75Mar 2, 26$76.22Mar 4, 26$72.21Mar 6, 26$71.35Mar 10, 26$69.96Mar 12, 26$68.55Mar 17, 26$71.20Mar 19, 26$69.89Mar 23, 26$69.54Mar 25, 26$69.78Mar 27, 26$69.17Mar 31, 26$62.75Apr 2, 26$62.82Apr 7, 26$61.86Apr 9, 26$61.28Apr 13, 26$63.18Apr 15, 26$64.61Apr 17, 26$64.23Apr 22, 26$64.87Apr 24, 26$62.07Apr 28, 26$58.45Apr 30, 26$57.61May 4, 26$56.85May 6, 26$56.00May 8, 26$53.93May 12, 26$54.10May 14, 26$53.55May 18, 26$55.92May 20, 26$56.67May 22, 26$57.78May 28, 26$49.11Jun 1, 26$47.98Jun 3, 26$47.69Jun 5, 26$48.55Jun 9, 26$48.96Jun 11, 26$47.17Jun 15, 26$46.76Jun 17, 26$44.95Jun 22, 26$44.33Jun 24, 26$44.46Jun 26, 26$44.23Jul 2, 26$45.14
$42.6852-week range$108.14
Loading valuation history…

Fundamentals

Key fundamentals

$71.7B

Market cap

19.9%

Revenue growth (YoY)

69.0%

Gross margin

$3.7B

Free cash flow (USD)

$10.4B

Net debt

0.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$8.4BFY 2017$9.0BFY 2018$9.8BFY 2019$10.7BFY 2020$9.9BFY 2021$11.9BFY 2022$12.7BFY 2023$14.2BFY 2024$16.7BFY 2025$20.1B
$8.4B$20.1B

Free cash flow by year

2016 → 2025

FY 2016$596.0MFY 2017$1.1BFY 2018$-6.0MFY 2019$1.4BFY 2020$1.1BFY 2021$1.3BFY 2022$914.0MFY 2023$1.7BFY 2024$2.6BFY 2025$3.7B
$596M$3.7B

Gross margin by year

2021 → 2025

FY 202162.8%FY 202260.8%FY 202362.0%FY 202461.3%FY 202569.0%
62.8%69.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

3

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $251KHabiger David C · Director · $251.1KMay 21, 2026Filing
  • Insider buyInsider Buy $203KLUDWIG EDWARD J · Director · $202.9KMay 21, 2026Filing
  • Insider buyInsider Buy $100KPegus Cheryl · Director · $100KMay 21, 2026Filing
  • 8-K eventInvestment AgreementMay 18, 2026Filing
  • 8-K eventAccelerated Share RepurchaseMay 18, 2026Filing
  • 8-K eventRestated Certificate of IncorporationMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 1, 2026Filing
  • 8-K eventEarnings ReleaseApr 22, 2026Filing

Questions

Frequently asked questions

What is Boston Scientific Corporation's market cap?

Boston Scientific Corporation (BSX) has a market capitalization of $71.7B.

What is BSX's P/E ratio?

BSX trades at a price-to-earnings ratio of 27.3, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is BSX's price-to-book (P/B) ratio?

BSX trades at 2.96 times book value per share.

Are insiders buying BSX stock?

Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at Boston Scientific Corporation in the last 90 days.

Same arena

Related companies in Medical - Devices

EW

Edwards Lifesciences Corporation

$49.6B

MDT

Medtronic plc

$95.6B

DXCM

DexCom, Inc.

$28.4B

RMD

ResMed Inc.

$28.3B

SYK

Stryker Corporation

$118.1B

PHG

Koninklijke Philips N.V.

$25.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.